SARAH MONTIEL: Open Payments
NPI 1396463220 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,223 in 45 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $324 · 2025 $1,223
Food & beverage: $1,223
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $530 |
| Novo Nordisk Inc | 9 | $240 |
| ABBVIE INC. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
| Astellas Pharma US Inc | 2 | $51 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $34 |
| Amgen Inc. | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: AIRSUPRA, Ozempic, BREZTRI, CAPLYTA, XIFAXAN, VRAYLAR, Veozah, UBRELVY.
Industry payments across AZ — which companies pay providers there.
